Dr. Khatija Dalvani, Dr. Chetna A. Jadeja*, Dr. Khyati Vaghela, Dr. Urmi Dave, Dr. Pratik Doshi and Dr. Vandana Parmar


Background: Electroconvulsive therapy (ECT) is commonly used for treatment of depression, mania, affective disorder etc. Sodium thiopentone is commonly used for anaesthetic management of ECT. Recovery profile of propofol is faster compared to thiopentone. Sevoflurane produces rapid and smooth induction and is rapidly eliminated for ease of recovery. Therefore, we compared sevoflurane with propofol with aim to know acceptability and recovery profile of both the agents for ECT. Materials and Methods: A total of 100 patients scheduled for ECT were randomly divided into Propofol (P) group and Sevoflurane (S) group of 50 each. Group-P patients received Inj. Propofol 1mg/kg i.v. and inj.succinyl choline 0.5 mg/kg i.v. Group-S patients received Sevoflurane 8%, followed by Sevoflurane 2% after loss of eye lash reflex and inj. succinyl choline 0.5 mg/kg was administered i.v. Onset of action, seizure duration, recovery profile , hemodynamics and side effects were noted. Results: Hemodynamics were comparable in both the groups. Seizure duration was 39±6.14sec in Group P, compared to 30.32±7.31sec in Group S and difference was statistically highly significant (p <0.0001). Recovery was assessed with time of following verbal command which was 343.42±63.77sec in Group P compared to 367.28±37.30sec in Group S and was statistically significant (p<0.05) , suggesting faster recovery with propofol compared tosevoflurane. Conclusions: Sevoflurane may offer an alternative anaesthetic induction agent for ECT especially when venous access is problematic from dehydration, agitation, disorientation, confusion or patients' intolerance to venepuncture. Both sevoflurane and propofol are acceptable for management of ECT. Propofol induction was associated with better recovery profile.

Keywords: Sevoflurane, propofol, electroconvulsive therapy, recovery, seizure duration.

[Full Text Article]   [Download Certificate]


Forgot Password  |  Register


Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Dr. Dhrubo Jyoti Sen

Download Article : Click here

News & Updation


    MAY 2024 Issue has been successfully launched on 1 MAY 2024.

  • EJBPS New Impact Factor

    EJBPS Impact Factor has been Increased to 7.482 for Year 2024.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.


  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.


UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS


Copyright From

Covering Letter

                        Author Instruction